Sickle Cell Disease Treatment Demonstration Program Regional Collaborative

Archived

Health Resources and Services Administration

Description

This announcement solicits applications for the Sickle Cell Treatment Demonstration Program Regional Collaborative. The purpose of this funding opportunity is to: (1) increase the number of providers that are treating sickle cell patients in the region; (2) increase the number of providers prescribing disease-modifying therapies, such as hydroxyrea; and (3) increase the number of sickle cell patients that are receiving care from providers with greater knowledge of how to treat sickle cell disease. This program will use collective impact strategies (see Collective Impact below) and collaborative learning to create Sickle Cell Regional Collaboratives that develop regional and sstate infrastructure to increase the number of providers providing disease-modifying therapies and enhancing the prevention and treatment of sickle cell disease through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with sickle cell disease.

Who can apply

  • Others

Contact

Department of Health and Human Services, Health Resources and Services Administration, HRSA Grants Application Center, 910 Clopper Road, Suite 155 South, Gaithersburg, MD, 20878<br/>CallCenter@HRSA.GOV<br/>
CallCenter@HRSA.GOV

Key dates & funding
  • PostedApr 24, 2014
  • ClosesMay 27, 2014
  • Award floor$0
  • Award ceiling$850,000
  • Program funding$3,400,000
  • Expected awards4
  • CFDA93.365
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro